Category: Clinical Trial
Clinical Trial market research reports by DelveInsight
-
Sickle Cell Disease (SCD) - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights Sickle cell disease (SCD) is a genetic blood disorder characterized by the presence of abnormal hemoglobin, causing red blood cells to become sickle-shaped. SCD is a global health concern, particularly prevalent in populations with African, Middle Eastern, Mediterranean, and South Asi ... Read More
-
Idiopathic Inflammatory Myositis - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 191,589 diagnosed prevalent cases of idiopathic inflammatory myositis in the 7MM. Of these, the United States accounted for 48% of the cases, while EU4 and the UK accounted for nearly 38% and Japan represented 14 ... Read More
-
Refractory Metastatic Melanoma - Pipeline Insight, 2025
DelveInsight’s, “Refractory Metastatic Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Refractory Metastatic Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025
DelveInsight’s, “Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Guillain-Barré Syndrome (GBS) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It al ... Read More
-
Chronic inflammatory demyelinating polyneuropathy (CIDP)- Pipeline Insight, 2025
DelveInsight’s, “Chronic inflammatory demyelinating polyneuropathy (CIDP)- Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 4+ pipeline drugs in Chronic inflammatory demyelinating polyneuropathy (CIDP)pipeline landscape. It covers the pipeline drug profiles, incl ... Read More
-
Androgen receptor antagonists - Pipeline Insight, 2025
DelveInsight’s, “Androgen receptor antagonists - Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Androgen receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025
“Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s development. The ... Read More
-
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025
“G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across G-Protein Coupled Receptor (GPCR) Agonist development. The report provides detailed coverage ... Read More
-
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2025
“Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Converting Enzyme (ACE) Inhibitor development. The report provides detailed ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025
“Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator development. The repor ... Read More
-
Androgen Antagonist - Pipeline Insight, 2025
“Androgen Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Androgen Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Androgen Agonist - Pipeline Insight, 2025
“Androgen Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Androgen Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
Alpha v Beta 5 Integrin Antagonist - Pipeline Insight, 2025
“Alpha v Beta 5 Integrin Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha v Beta 5 Integrin Antagonist development. The report provides detailed coverage of the pipeli ... Read More
-
Alpha Receptor Agonist - Pipeline Insight, 2025
“Alpha Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha Receptor Agonist development. The report provides detailed coverage of the pipeline landscape for this me ... Read More
-
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025
“Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- development. The report provides detailed coverage ... Read More
-
Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025
“Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist development. The rep ... Read More
-
Adrenergic Antagonist - Pipeline Insight, 2025
“Adrenergic Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adrenergic Antagonist development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
Adenosine A2A Receptor Agonist - Pipeline Insight, 2025
“Adenosine A2A Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2A Receptor Agonist development. The report provides detailed coverage of the pipeline lands ... Read More
-
Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2B Receptor Antagonist development. The report provides detailed coverage of the pipeline ... Read More
-
Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The Ulcerative Colitis Market Size in the 7MM was around USD 8,400 Million in 2023. The Ulcerative Colitis Market is anticipated to witness a positive shift owing to better uptake of existing drugs, and raised awareness. Ulcerative Colitis treatment is complex and comprises the use of ... Read More
-
TCR Therapy- Pipeline Insight, 2025
DelveInsight’s, “TCR Therapy- Pipeline Insight, 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in TCR Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessm ... Read More
-
Postmenopausal Osteoporosis - Pipeline Insight, 2025
DelveInsight’s, “Postmenopausal Osteoporosis - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Postmenopausal Osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More
-
AXL Inhibitors - Pipeline Insight, 2025
DelveInsight’s, “AXL Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 16+ companies and 20+ pipeline drugs in AXL Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
IgG4-Related Disease - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights IgG4-RD can affect virtually any organ, with common presentations including the pancreas, bile ducts, salivary glands, lacrimal glands, orbits, kidneys, lungs, and retroperitoneum. The true prevalence of IgG4-RD is unknown. Given its relatively recent discovery, lack of widespread rec ... Read More
-
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025
“Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Recepto ... Read More
Research Assistance
